Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02640508
Title Eribulin and Lenvatinib in Advanced Solid Tumors
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors Virginia G. Kaklamani
Indications

lung non-small cell carcinoma

breast cancer

sarcoma

Therapies

Eribulin + Lenvatinib

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Cancer Therapy and Research Center University of Texas Health Science Center San Antonio San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field